Grifols, Brookfield
EST Brookfield still pursuing Grifols (GRFS) deal, Bloomberg reports Published first on TheFly – the ultimate source for ...
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to ...
The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...
Berenberg Bank upgraded shares of Grifols (NASDAQ:GRFS – Free Report) to a strong-buy rating in a report released on Tuesday, Zacks.com reports. Grifols Price Performance Shares of NASDAQ GRFS opened ...
Overview: Grifols, S.A. is a plasma therapeutic company operating in Spain, the United States, Canada, and internationally with a market cap of approximately €6.40 billion. Operations ...
Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasis Grifols surgical bleeding management ...
Police were called to the scene about 3 p.m. A man was pronounced dead and another was in custody, officials said.
BARCELONA, Spain, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced it ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback